Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Aphomia sociella isolate:RMS-2025

ABSTRACT: Aphomia sociella isolate:RMS-2025

PROVIDER: PRJNA1276471 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR34022944_1.fastq.gz	Fastqsanger.gz
	SRR34022945_1.fastq.gz	Fastqsanger.gz
	SRR34022945_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Transcription profiling of human Rhabdomyosarcoma biopsy samples (15 embryonal RMS, 10 translocation-positive alveolar RMS and 5 translocation-negative alveolar RMS)

Project description:We measured the expression profiles of a series of 30 Rhabdomyosarcoma biopsy samples (15 embryonal RMS, 10 translocation-positive alveolar RMS and 5 translocation-negative alveolar RMS). Expression data was used for unsupervised hierarchical clustering as well as supervised analysis to find gene expression signatures characteristic for the different histological RMS subgroups.

2004-06-30 | E-MEXP-121 | biostudies-arrayexpress

Citrobacter freundii strain:2025-PB04 | isolate:2025-PB04

Project description:Citrobacter freundii strain:2025-PB04 | isolate:2025-PB04 Genome sequencing

| PRJNA1320841 | ENA

Aeromonas veronii strain:AVW-2025 | isolate:AVW-2025

Project description:Aeromonas veronii strain:AVW-2025 | isolate:AVW-2025 Genome sequencing

| PRJNA1328245 | ENA

Salvelinus malma isolate:YT-2025

Project description:Salvelinus malma isolate: 2025 Genome sequencing

| PRJNA1289388 | ENA

Rhabdomyosarcoma surfaceome profiling with six fusion-positive (FP) RMS cell lines, five fusion-negative (FN) RMS cell lines, and three ARMS patient-derived xenografts (PDXs)

Project description:Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Prognosis for patients with high grade and metastatic disease is still very poor, and survivors are burdened with long-lasting side effects. Therefore, more effective and less toxic therapies are needed. Surface proteins are ideal targets for antibody-based therapies, like bispecific antibodies, antibody drug conjugates, or chimeric antigen receptor (CAR) T cell. Specific surface targets for RMS are scarce. Here, we performed a surfaceome profiling based on differential centrifugation enrichment of surface/membrane proteins and detection by LC-MS on six fusion-positive (FP) RMS cell lines, five fusion-negative (FN) RMS cell lines, and three RMS patient-derived xenografts (PDXs). 699 proteins were detected in the three RMS groups. Ranking based on expression levels and comparison to expression in normal MRC-5 fibroblasts and myoblasts, followed by statistical analysis, highlighted known RMS targets such as FGFR4, NCAM1, and CD276/B7-H3, and revealed AGRL2, JAM3, MEGF10, GPC4, CADM2, as potential targets for immunotherapies of RMS. L1CAM expression was investigated in RMS tissues and strong L1CAM expression was observed in more than 80% of alveolar RMS tumors, making it a practicable target for antibody-based therapies of alveolar RMS.

2023-03-11 | PXD039480 | Pride

Euterpe oleracea isolate:SC-2025

Project description:Euterpe oleracea isolate:SC-2025 Genome sequencing

| PRJNA1266257 | ENA

Eleutheronema rhadinum isolate:ZW-2025

Project description:Eleutheronema rhadinum isolate:ZW-2025 Genome sequencing

| PRJNA1222184 | ENA

Hypomesus nipponensis isolate:CZN-2025

Project description:Hypomesus nipponensis isolate:CZN-2025 Genome sequencing

| PRJNA1280294 | ENA

Elysia leucolegnote isolate:GZ-2025

Project description:Elysia leucolegnote isolate:GZ-2025 Genome sequencing